On Friday, Tarsus Pharmaceuticals Inc (NASDAQ: TARS) opened higher 6.66% from the last session, before settling in for the closing price of $43.57. Price fluctuations for TARS have ranged from $20.08 to $57.28 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 172.29% over the last five years. Company’s average yearly earnings per share was noted 42.49% at the time writing. With a float of $33.09 million, this company’s outstanding shares have now reached $38.35 million.
The firm has a total of 323 workers. Let’s measure their productivity. In terms of profitability, gross margin is 92.99%, operating margin of -65.9%, and the pretax margin is -63.16%.
Tarsus Pharmaceuticals Inc (TARS) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Tarsus Pharmaceuticals Inc is 13.77%, while institutional ownership is 102.10%. The most recent insider transaction that took place on Aug 12 ’24, was worth 912,961. In this transaction Director of this company sold 35,000 shares at a rate of $26.08, taking the stock ownership to the 0 shares. Before that another transaction happened on Aug 12 ’24, when Company’s Director proposed sale 35,000 for $26.85, making the entire transaction worth $939,750.
Tarsus Pharmaceuticals Inc (TARS) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.4 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 42.49% per share during the next fiscal year.
Tarsus Pharmaceuticals Inc (NASDAQ: TARS) Trading Performance Indicators
Check out the current performance indicators for Tarsus Pharmaceuticals Inc (TARS). In the past quarter, the stock posted a quick ratio of 4.39. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9.75.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.10, a number that is poised to hit -0.81 in the next quarter and is forecasted to reach 1.10 in one year’s time.
Technical Analysis of Tarsus Pharmaceuticals Inc (TARS)
Analysing the last 5-days average volume posted by the [Tarsus Pharmaceuticals Inc, TARS], we can find that recorded value of 0.55 million was lower than the volume posted last year of 0.66 million. As of the previous 9 days, the stock’s Stochastic %D was 55.85%. Additionally, its Average True Range was 2.73.
During the past 100 days, Tarsus Pharmaceuticals Inc’s (TARS) raw stochastic average was set at 52.19%, which indicates a significant decrease from 55.75% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 64.06% in the past 14 days, which was higher than the 50.76% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $50.18, while its 200-day Moving Average is $38.85. Now, the first resistance to watch is $47.72. This is followed by the second major resistance level at $48.97. The third major resistance level sits at $51.17. If the price goes on to break the first support level at $44.27, it is likely to go to the next support level at $42.07. Now, if the price goes above the second support level, the third support stands at $40.82.
Tarsus Pharmaceuticals Inc (NASDAQ: TARS) Key Stats
There are currently 38,377K shares outstanding in the company with a market cap of 1.78 billion. Presently, the company’s annual sales total 182,950 K according to its annual income of -115,550 K. Last quarter, the company’s sales amounted to 66,410 K and its income totaled -23,110 K.
